Capillary Technologies India Limited
CAPILLARY (NSE) · CAPILLARY (BSE 544614) · ISIN INE0ILV01024 · Software Products · Est. 2012 · listed 2025 · website
Not on any surveillance list
In Q1 FY27 (quarter to 30 June 2026, standalone), revenue was ₹64.29 cr and profit after tax ₹7.76 cr.
Next: Board meeting: financial results on 2 November 2026.
Open the full company file Every section, filings and your notes, in the app.
Quarterly results
| Quarter | Revenue | Profit after tax | EPS (₹) | Filed |
|---|---|---|---|---|
| Q1 FY27 standalone | ₹64.29 cr | ₹7.76 cr | 0.97 | 4 Aug 2026 |
| Q4 FY26 standalone | ₹65.02 cr | ₹9.89 cr | 1.23 | 6 May 2026 |
| Q3 FY26 standalone | ₹57.98 cr | ₹1.05 cr | 0.14 | 6 Feb 2026 |
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹823.2 cr | ₹44.72 cr | ₹964.63 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 47.23% | 2.56% | 21.87% | 52.77% |
Latest filings
- Capillary Technologies India Limited has informed the Exchange about Transcript 10 August 2026 · NSE
- Capillary Technologies India Limited has informed the Exchange about Transcript 10 August 2026 · NSE
- Capillary Technologies India Limited has informed the Exchange about Investor Presentation 4 August 2026 · NSE
- Capillary Technologies India Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. 4 August 2026 · NSE
- Capillary Technologies India Limited has informed the Exchange about Investor Presentation 4 August 2026 · NSE
Other companies in Software Products
- Oracle Financial Services Software Limited
- Nucleus Software Exports Limited
- Tanla Platforms Limited
- C.E. Info Systems Limited
- Ramco Systems Limited
- Subex Limited
- Quick Heal Technologies Limited
- Virinchi Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.